Full Text View
Tabular View
No Study Results Posted
Related Studies
Third Year Evaluation on Genistein Efficacy and Safety
This study has been completed.
Study NCT00626769   Information provided by University of Messina

First Received on February 19, 2008.   Last Updated on May 18, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Menopause
Osteopenia
Additional conditions recognized in this trial
Bone Diseases, Metabolic
More general conditions related to this trial
Bone Diseases
Musculoskeletal Diseases
Interventions listed in this trial
aglycone genistein
placebo
Additional drug interventions recognized in this trial
Genistein
More general drug interventions related to this trial
Anticarcinogenic Agents
Antineoplastic Agents
Enzyme Inhibitors
Estrogens
Estrogens, Non-Steroidal
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Phytoestrogens
Protective Agents
Protein Kinase Inhibitors
Therapeutic Uses
Sponsors listed in this trial
University of Messina
Primus Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services